RapidCME

RapidCME Library - Dementia

  • Page 1 of 1
  • 1
  • Individualizing Symptomatic Therapies for Alzheimer’s Disease
    Release Date: March 17, 2023, Expiration Date: March 17, 2024

    Alzheimer’s disease expert Richard S. Isaacson, MD, explores strategies for care collaboration to optimize care for patients with Alzheimer’s disease (AD), the importance of determining patient-specific pharmacologic treatment approaches for patients with AD, and implementing approaches for effective communication with patients and caregivers surrounding AD diagnosis and management.

  • Navigating Recent Advances in Alzheimer’s Disease: Expert Insights on Neuropathological Diagnostic Markers and the Clinical Potential of Novel Disease-Modifying Therapies
    Release Date: September 14, 2022, Expiration Date: September 14, 2023

    What role do biomarkers play in Alzheimer’s disease (AD)? The availability of a new pharmacologic class for AD offers the potential for disease modification when added early in the disease course, emphasizing the importance of novel biomarkers. In this podcast, experts review the association between biomarkers and symptoms of AD, the use of biomarkers for the early detection of AD, and the potential of available and emerging disease-modifying therapies for AD.

  • Page 1 of 1
    Results 1-2 of 2
  • 1